Research in mice reveals how critical brain cells misfire in Alzheimer’s and identifies a targeted strategy to restore healthy brain rhythms.
Category: neuroscience – Page 6
A foundational model redirects cell fate with just a single stimulus
Which genes need to be controlled to guide a stem cell toward a desired cell type, or to modulate an immune cell’s inflammatory response? A research team has developed a general-purpose computational framework that identifies the key targets needed to steer a cell toward a desired state with a single temporary intervention, without permanently altering its genes.
NUDGE, a foundational technology that redirects cell fate in a desired direction through a minimal, temporary intervention by harnessing the gene regulatory dynamics already present within cells.
Technologies that redirect cell fate have drawn attention as key tools for treating intractable diseases and advancing regenerative medicine, since they can be used to differentiate stem cells into cells with specific functions or to return diseased or aged cells to a near-normal state. Differentiation, for example, refers to the process by which a stem cell becomes a specific cell type with a distinct function, such as a cardiomyocyte or a neuron.
The Neuro Revolution Is Dawning. Are We Ready?
Georgia Tech researchers are exploring new frontiers in neuroethics: to ensure that emerging neurotechnologies can be used for the good of all and to ensure that we won’t inadvertently relinquish crucial human rights which have yet to be legally defined.
[ https://news.research.gatech.edu/feature/neuro-society](https://news.research.gatech.edu/feature/neuro-society)
As neuroscience and neurotechnology accelerate, Georgia Tech researchers are examining what a neuro-connected future could mean for society and for humanity itself.
You Have the Power to Become Master of Your Own Reality—and One Neuroscientist Knows How to Unlock It
It’s easier than you’d think—you just need one key ingredient.
ASCL1 and OLIG2 Expression Dynamics Control Glial Cell Fate and Regional Diversity in the Dorsal Forebrain
Gliogenesis is a multistep process in which glial progenitors are specified into migrating and proliferating precursor cells that subsequently differentiate into mature astrocytes and oligodendrocytes. How these developmental processes are coordinated to generate the diverse glial lineages across gray matter (GM) and white matter (WM) remains poorly understood. Here, we show that the basic-helix-loop-helix (bHLH) transcription factor ASCL1 serves as a direct mechanistic link between these processes in the dorsal forebrain. Notably, ASCL1 is dynamically expressed in glial progenitor cells, initiating in the ventricular zone (VZ), peaking in the intermediate zone (IZ), but is downregulated once glial cells enter the cortical plate. Lineage tracing of ASCL1+ progenitors demonstrates that they subsequently co-express OLIG2 to generate both astrocytes and oligodendrocytes in an “outside-in” pattern starting from the upper cortex inward to the corpus callosum, the opposite pattern of neurogenesis. ASCL1 gain-of-function combined with OLIG2 loss-of-function reveals that sustained levels of ASCL1 are essential to induce sufficient levels of OLIG2 required to specify oligodendrocyte precursor cell (OPC) fate. Interestingly, a persistent ASCL1 expression also maintains OPCs in an undifferentiated, pre-neoplastic state into postnatal stages, in part by suppressing their differentiation into postmitotic oligodendrocytes. Together, these findings establish ASCL1 as a key regulator of the spatiotemporal order of glial lineage diversity in cortical GM and callosal WM, and highlight ASCL1 dysregulation as an underlying developmental mechanism in the pathogenesis of gliomas.
Significance statement The brain relies on macroglia to form the blood-brain-barrier, insulate nerve fibers, and regulate neuronal signaling; yet how these cell types are generated remains poorly understood. This study shows that the timing and levels of two key regulatory proteins, ASCL1 and OLIG2, function together to guide immature glial cells through distinct stages of development. Notably, we show that brief ASCL1 activity followed by sustained ASCL1 and OLIG2 levels coordinate when glial cells form, the cell type they become, and where they migrate to reside in the cerebral cortex. By revealing the developmental program underlying the generation of glial cell diversity, this study provides a framework for understanding how glial-related neurological diseases and cancer arise in the brain.
Researchers Transform Old Blood Cells into Young Brain Cells
Researchers from the University Hospital of Bonn and the University of Bonn have succeeded in dramatically rejuvenating human cells in a test tube. To do so, they directly reprogrammed red blood cell precursors into stem cells from which neurons can be derived. During this process, the molecular clocks that indicate a cell’s age were reset. For example, blood cells from an 80-year-old were transformed into stem cells with a molecular age of less than 20 years. Since this rejuvenation process occurred very slowly, it is well-suited for a more detailed investigation of the underlying mechanisms. The results have been published in the journal Aging Cell.
Study: Aging Cell Abstract Protracted Fate Acquisition and Epigenetic De-Aging During Induced Neural Stem C https://onlinelibrary.wiley.com/doi/10.1111/acel.70751ell Conversion of Human Blood Cells.
The human body contains hundreds of different cell types. They all originate from the fertilized egg and therefore share the same genetic makeup. However, in the course of their development, they were committed to a specific fate: a skin cell cannot naturally become a liver cell, nor can a blood cell become a nerve cell.
Today, however, it is possible to reverse this determination in the laboratory. For example, nerve tissue can be grown from a skin cell, which may one day be used to treat neurodegenerative diseases. To achieve this reprogramming, researchers use a cocktail of various transcription factors. These factors cause the cell to read different genetic instructions and thus embark on a different developmental path.
Molecular clocks are reset dramatically
“Using this method, we have directly converted red blood cell precursors into neural stem cells,” explains Prof. Dr. Oliver Brüstle, director of the Institute of Reconstructive Neurobiology at the University Hospital of Bonn. In previous studies, the Bonn researchers had already shown that nerve cells produced in this way form connections with existing neurons after transplantation into the brains of mice.
Using light to control brain cells explains how he made his Nobel-winning discovery
2026 Nobel Prize in physiology or medicine honored Karl Deisseroth, Peter Hegemann and Georg Nagel for their work developing optogenetics – a technique that allows researchers to control the activity of neurons with light.
The Conversation Weekly podcast talked to Karl Deisseroth, a neuroscientist at Stanford University, about his journey developing optogenetics and its potential to treat a wide range of neuropsychiatric conditions. What follows is an edited transcript of the podcast.
Take us back to the early 1990s. You’re training to be a doctor and you start a rotation working with psychiatric patients. What questions about the brain did that raise for you?
The hidden math of Alzheimer’s could point to new treatments
Mathematics may hold unexpected clues to understanding Alzheimer’s disease. Scientists have developed a model showing how common metals like copper and zinc may influence the buildup of proteins associated with the disease, while also exploring possible ways to stop the process. The findings could help researchers identify promising strategies for preventing harmful plaque formation.
Scientists found a surprising driver of Alzheimer’s outside the brain
Scientists found that immune cells contributing to Alzheimer’s-related brain damage may be activated in lymph nodes outside the brain before traveling into the nervous system. Blocking this pathway in mice dramatically reduced neurodegeneration and preserved cognitive abilities, pointing to a potentially more accessible treatment target.
New drug-delivery method offers promise in fight against neurodegenerative diseases
For patients battling neurodegenerative diseases like ALS, Parkinson’s, Alzheimer’s and other dementias, delivering disease-fighting antibody drugs directly to the brain has proven to be a difficult task. Our bodies set up tight walls to prevent infections from spreading to the brain, where they often become fatal.
Unfortunately, this protective feature also prevents us from getting drugs into the brain. Approximately 1 in 10,000 antibodies injected into patients actually makes it to the brain, with these cellular fighters trapped in the blood rather than escaping through cracks in the blood vessels into the brain.
Now, researchers have mapped out a new transit process to enable drugs to reach the brain using extracellular vesicles—tiny bubbles naturally produced by cells in our bodies.









